BLTE
BELITE BIO INC - ADRData as of 2026 Q2 (06-30) · 13F snapshot
Summary
BELITE BIO INC - ADR (BLTE) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$137.63M; the largest are Izzy Englander, Ken Griffin, Stanley Druckenmiller. This quarter: 1 new, 2 added, 1 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders5
Congress trades0
Price$166.66vs quarter-end+8.23%
Sectors0
This quarter's moves
Top holderNew1
Added2
Trimmed / sold2
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $16.34M0.4% of portfolio106,1002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Stanley Druckenmiller | $16.34M | 0.4% | Hold |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.